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Abstract
Introduction: Enteral feeding can be given either through the nasogastric or the nasojejunal route. Studies have
shown that nasojejunal tube placement is cumbersome and that nasogastric feeding is an effective means of providing
enteral nutrition. However, the concern that nasogastric feeding increases the chance of aspiration pneumonitis and
exacerbates acute pancreatitis by stimulating pancreatic secretion has prevented it being established as a standard of
care. We aimed to evaluate the differences in safety and tolerance between nasogastric and nasojejunal feeding by
assessing the impact of the two approaches on the incidence of mortality, tracheal aspiration, diarrhea, exacerbation of
pain, and meeting the energy balance in patients with severe acute pancreatitis.
Method: We searched the electronic databases of the Cochrane Central Register of Controlled Trials, PubMed, and
EMBASE. We included prospective randomized controlled trials comparing nasogastric and nasojejunal feeding in
patients with predicted severe acute pancreatitis. Two reviewers assessed the quality of each study and collected
data independently. Disagreements were resolved by discussion among the two reviewers and any of the other
authors of the paper. We performed a meta-analysis and reported summary estimates of outcomes as Risk Ratio
(RR) with 95% confidence intervals (CIs).
Results: We included three randomized controlled trials involving a total of 157 patients. The demographics of the
patients in the nasogastric and nasojejunal feeding groups were comparable. There were no significant differences
in the incidence of mortality (RR = 0.69, 95% CI: 0.37 to 1.29, P = 0.25); tracheal aspiration (RR = 0.46, 95% CI: 0.14
to 1.53, P = 0.20); diarrhea (RR = 1.43, 95% CI: 0.59 to 3.45, P = 0.43); exacerbation of pain (RR = 0.94, 95% CI: 0.32
to 2.70, P = 0.90); and meeting energy balance (RR = 1.00, 95% CI: 0.92 to 1.09, P = 0.97) between the two groups.
Nasogastric feeding was not inferior to nasojejunal feeding.
Conclusions: Nasogastric feeding is safe and well tolerated compared with nasojejunal feeding. Study limitations
included a small total sample size among others. More high-quality large-scale randomized controlled trials are
needed to validate the use of nasogastric feeding instead of nasojejunal feeding.
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Introduction
Severe acute pancreatitis (SAP) is characterized by high
mortality rates and is a potentially lethal disease requiring
nutritional support [1]. Nutritional support is considered a
key issue in the management of the hypercatabolism sec-
ondary to extended pancreatic and extrapancreatic
inflammation.
Parenteral nutrition (PN), which has been associated
with a greater complication rate [2], was the preferred
route in the past. PN results in a major breakdown of the
gut mucosal defense barrier with subsequent bacterial/
endotoxin translocation, leading to sepsis and infections
locally and at distant sites. Clinical prospective studies
have shown that increased intestinal permeability corre-
lates with increased levels of endotoxin and also with the
grade of severity of pancreatitis [3,4].
Recently, convincing evidence has demonstrated that
compared with PN, enteral nutrition (EN) significantly
reduces infectious complications and mortality [5,6],
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results in decreased organ failure and surgical interven-
tion rate [2] and provides significantly better glycemic
control [7] in predicted SAP. EN may improve outcomes
in these patients if given early [8]. Nutritional support
using EN should be the preferred method in patients
with SAP [2,9,10] as recommended by current guidelines
[11].
EN can be given through either the nasogastric (NG)
or the nasojejunal (NJ) route. While most studies have
shown that NJ feeding is an effective method of provid-
ing EN for patients with SAP, there are also successful
studies using NG feeding [12-14].
NJ tube placement is cumbersome because, although
both fluoroscopy and endoscopy are highly effective for
placement of small bowel feeding tubes, it can take an
experienced operator up to 30 minutes to achieve post-
pyloric placement of a small bowel feeding tube [15]. In
contrast, NG tube placement is an easy bedside proce-
dure. Therefore, NJ tube placement is expensive and
inconvenient compared with NG tube placement.
Traditionally, it was believed that stimulation of pan-
creatic secretion by EN is detrimental. NG or duodenal
feeding has been believed to increase the chances of
aspiration pneumonitis [16] and stimulate pancreatic
secretion [17] resulting in inefficient restoration of gut
mucosal integrity, whereas NJ feeding did not.
The aim of nutritional support is to meet the patient’s
elevated metabolic demands as much as possible without
stimulating pancreatic secretion while maintaining gut
integrity [8]. The first meta-analysis and systemic review
by Petrov et al. [18] was encouraging by showing no sig-
nificant differences between NG and NJ feeding regard-
ing safety and tolerance. This study was expected to
contribute greatly to the establishment of an ideal nutri-
ent feeding approach in patients with SAP. However,
well-designed and sufficiently powered randomized con-
trolled trials (RCTs) on NG versus nasointestinal feeding
are required before early NG feeding can be established
as a standard of care [19]. It is believed that small-scale
clinical trials can lead to erroneous conclusions [20,21].
In order to compare tolerance and clinical outcomes
between NG and NJ feeding, we performed a meta-ana-
lysis because adequately powered data derived from
RCTs comparing NG and NJ feeding in SAP are scarce
[12] and the ideal route for EN remains to be estab-
lished. We used mortality, tracheal aspiration, diarrhea
and exacerbation of pain as the primary outcomes to
assess the impact of NG and NJ feeding in patients with
predicted SAP because tracheal aspiration, diarrhea and
exacerbation of pain are concerns in NG feeding and
mortality is an important variable used in evaluating (a




We used a multi-method iterative approach to identify
relevant studies and we conducted a computerized lit-
erature search of the PubMed database from 1966 to
October 2012 using the following search terms: severe
acute pancreatitis AND nasogastric or nasojejunal AND
nutrition or feeding. We also searched the Cochrane
Central Register of Controlled Trials and the EMBASE
(1980 to 2012) databases with the same terms. Refer-
ences that included information on EN were screened in
an attempt to find other relevant articles. There were no
restrictions on publication language.
Study selection and data extraction
We defined the publications included in this meta-analysis
using the following selection criteria: 1) study design:
RCTs; 2) population: hospitalized patients with predicted
SAP; and 3) intervention: NG versus NJ feeding. We used
the following outcome variables: the primary outcome was
mortality and at least one of the following variables: inci-
dence of tracheal aspiration, diarrhea and exacerbation of
pain; the secondary outcome was achievement of energy
balance. A structured data abstraction form was used to
ensure completeness and consistency of appraisal for each
study. We extracted study characteristics, methodological
variables, intervention, participant characteristics, clinical
variables and outcome measures. Article selection and
data extraction were conducted independently by two
authors. All disagreements were resolved by discussion
among these two authors and any of the other authors of
the paper.
Quality assessment and statistical analysis
The quality of the included trials was assessed using a
Jadad score [22]. Meta-analysis was performed using the
Cochrane Collaboration’s Review Manager Software 5
(RevMan 5.0). The risk ratio outcomes are presented
with 95% confidence intervals. Heterogeneity between
trials was tested using the chi-square test, with P < 0.10
indicating significant heterogeneity (difference) [23]. A
random effects model and a fixed effects model were
used in the presence and absence of statistical heteroge-
neity, respectively. We used a funnel plot to uncover
potential publication bias.
Results
Sixty articles met the search criteria and 56 were
excluded after screening to include only the studies com-
paring NG versus NJ or nasointestinal feeding. Of the
four remaining articles, three were RCTs and one was a
non-randomized cohort study [19]; therefore, three eligi-
ble RCTs were included in the analysis (Figure 1) [12-14].
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The characteristics of the included studies are summar-
ized in Table 1 and the quality of the included RCTs is
shown in Table 2.
In the study by Eatock et al. [12], predicted SAP was
defined as both the clinical and biochemical signs of acute
pancreatitis and objective evidence of disease severity
(Glasgow prognostic score of three or more or an Acute
Physiology and Chronic Health Evaluation (APACHE) II
score of six or higher or a C-reactive protein level greater
than 150 mg/L). In the other two studies [13,14], predicted
SAP was defined as a diagnosis of acute pancreatitis and at
least one of three additional criteria: single or multiple
organ failure as defined by the Atlanta classification; an
APACHE II score of ≥8; and computed tomography sever-
ity index of ≥7. Overall, 157 patients with predicted SAP
were enrolled in the included studies. Of these, 82 were
randomly assigned to an NG group and 75 to an NJ
group. Baseline demographic parameters of all subjects in
the RCTs are shown in Table 3. There was no significant
difference between the NG and NJ feeding groups at
admission with respect to the demographic parameters,
including multiple organ failure (MOF) and infected pan-
creatic necrosis (IPN). The baseline demographic data of
the patients receiving the NG and NJ approaches were
comparable. The main clinical outcomes of the NG and
NJ groups in the included studies are shown in Tables 4
and 5, respectively. The severity of the patients at admis-
sion was comparable in the three included studies on the
basis of the APACHE II score. The length of hospital stay
(LOS) and duration of EN in the NG and NJ groups in all
of the included studies were comparable.
All the included RCTs reported the mortality, occur-
rence of diarrhea, exacerbation of pain and achievement of
energy balance. Two RCTs from a single center [13,14]
reported tracheal aspiration. Patients tolerating a rate of at
least 75% of the target calories within 60 hours were con-
sidered to have achieved energy balance in the study from
Scotland [12] with only one patient converted to intrave-
nous feeding from the NJ group. In contrast, in the study
by Kumar et al. [13], the achievement of energy balance
56 excluded for not referring to 
comparison on NG and NJ feeding 
1 non randomized controlled trail 
was excluded 
60 Non duplicate records identified 
in initial database search 
4 studies remained for qualitative 
synthesis 
3 eligible studies included in the 
final analysis 
Figure 1 Search, inclusion, and exclusion flow diagram.
Table 1 Characteristics of included RCTs




Eatock 2005 UK RCT < 72 hours after onset Semielemental Yes Adequate
Kumar 2006 India RCT 48 to 72 hours of admission Semielemental Unclear Unclear
Singh 2012 India RCT 48 hours of admission Semielemental Yes Adequate
ITT, intention-to-treat analysis; RCT, randomized controlled trial.
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was defined by patients reaching a goal of 1,800 kcal
within seven days from the start of feeding. Partial PN was
necessary in only four and six patients in the NJ and NG
groups, respectively. Patients achieving the goal nutrient
requirement of 25 kcal/kg per day were considered to
have achieved energy balance in the study by Singh et al.
[14], and no additional PN was used. No heterogeneity
(P = 0.64, 0.76, 0.51, 0.85, 1.00, respectively) was observed
between the study results for all comparisons (Figures 2 to
6); therefore, a fixed effects model was used.
The number of deaths, tracheal aspiration, exacerbation
of pain, diarrhea, and achievement of energy balance was
14 (17.1%), 3 (5.5%), 6 (7.3%), 11 (13.4%) and 76 (92.7%) in
the early NG group, respectively. In the NJ group, the
numbers were 18 (24.0%), 7 (13.2%), 6 (8%), 7 (9.3%) and
70 (93.3%), respectively (Figure 7). The mortality rate is
consistent with previous reports. No cases required with-
drawal of the enteral feeding due to recurrent re-feeding
pain. There were no significant differences in the inci-
dence of mortality (RR = 0.69, 95% CI: 0.37 to 1.29, P =
0.25, Figure 2); tracheal aspiration (RR = 0.46, 95% CI:
0.14 to 1.53, P = 0.20, Figure 3); exacerbation of pain
(RR = 0.94, 95% CI: 0.32 to 2.70, P = 0.90, Figure 4); diar-
rhea (RR = 1.43, 95% CI: 0.59 to 3.45, P = 0.43, Figure 5);
or achievement of energy balance (RR = 1.00, 95% CI: 0.92
to 1.09, P = 0.97, Figure 6) between the NG and NJ feed-
ing groups.
There were differences between patients in the studies
from Scotland and India with respect to gender and etiol-
ogy (P = 0.02, 0.02, respectively) (Table 6).
Visual inspection of the funnel plot (Figure 8) did not
indicate a publication bias.
Discussion
Outcomes based on the analysis of the data from the
three included RCTs were within the expected range.
Eatock et al. [24] used early NG feeding in the nutritional
management of SAP, followed by oral re-feeding [25] in
patients with predicted SAP. It has been shown that NG
feeding is feasible in up to 80% of cases [12]. Similarly,
our meta-analysis showed that the safety and tolerance
were not significantly different between the NG and NJ
feeding groups, with no increase in mortality or nutri-
tion-associated adverse events. As shown in Table 3,
there was no significant difference between the NG and
NJ feeding groups at admission with respect to MOF and
IPN. Because primary or secondary infection of necro-
tized areas by enteral bacteria is considered a primary
cause of mortality in patients with SAP, which is charac-
terized by rapidly progressive MOF [26], we can conclude
that the severity of the disease in the NG and NJ feeding
groups was equivalent at admission, validating the com-
parison of NG and NJ feeding. APACHE II scores can
provide better prediction of mortality in patients with
SAP [27]. Similar to MOF and IPN, APACHE II scores in
the NG and NJ feeding groups at admission were com-
parable in all of the included studies (Table 4 and 5,
respectively), further validating our analysis.
NG or duodenal feeding has been believed to increase
the chances of aspiration pneumonitis [16], but our results
showed no significant difference between NG and NJ feed-
ing with respect to tracheal aspiration, suggesting that NG
feeding is as safe as NJ feeding. Also, Marik et al. [15]
























Not used Two excluded in NJ for refusal of NJ tube re-insertion 3
The methodological quality of the randomized studies included was estimated using the criteria proposed by Jadad et al. [22]. NG, nasogastric; NJ, nasojejunal.
Table 3 Baseline demographic parameters of total












Alcohol 22 20 0.10
Idiopathic 16 12
Others 8 1
MOF 14 18 0.28
IPN 16 23 0.11
Mortality 14 18 0.25
IPN, infected pancreatic necrosis; MOF, multiple organ failure; RCTs,
randomized controlled trials.
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demonstrated no benefit from post-pyloric versus gastric
tube feeding in a mixed group of critically ill patients with
respect to tracheal aspiration. Delayed gastric emptying
leads to impaired upper digestion and results in some
degree of upper digestive intolerance [28]. Also, placement
of small bowel feeding tubes using the blind nasoenteric
approach is technically challenging and not as convenient
or as easy as the placement of gastric feeding tubes. Mis-
placement of small bore feeding tubes into the lung with
resultant pneumothorax is not a rare complication [15].
Table 4 Outcomes of patients receiving nasogastric feeding in the studies included
Study Number of patients Age
(years)
APACHE II score LOS
(days)
Duration of EN (days)
Eatock 2005 27 63 (47 to 74)a 10 (7 to 18)a 16 (10 to 22)a 5
Kumar 2006 16 43.3 ± 12.8b 10.5 ± 3.8b 24.1 ± 14.4b 7
Singh 2012 39 39.1 ± 16.7b 8.5 (2 to 19)a 17 (1 to 73)a 7 or longer
Total 82 - - - -
aValues are median (range); bValues are mean±standard deviation; APACHE, Acute
Physiology and Chronic Health Evaluation; LOS, length of hospital stay.
Table 5 Outcomes of nasojejunally-fed patients in the studies included
Study Number of patients Age
(years)
APACHE II score LOS
(days)
Duration of EN (days)
Eatock 2005 22 58 (48 to 64)a 12 (8 to 14)a 15 (10 to 24)a 5
Kumar 2006 14 35.6 ± 12.5b 9.6 ± 5.0b 29.9 ± 25.5b 7
Singh 2012 39 39.7 ± 12.3b 8 (2 to 24)a 18 (4 to 54)a 7 or longer
Total 75 - - - -
aValues are median (range); bValues are mean±standard deviation; APACHE, Acute
Physiology and Chronic Health Evaluation; EN, enteral nutrition; LOS, length of hospital stay.
Figure 2 Comparison of overall mortality between nasogastric feeding and nasojejunal feeding groups.
Figure 3 Comparison of tracheal aspiration between nasogastric feeding and nasojejunal feeding groups.
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Although both fluoroscopy and endoscopy are highly
effective for placement of small bowel feeding tubes, both
techniques are expensive and inconvenient [15].
The effect of nutrition on pancreatic exocrine function is
one of the most important issues concerning NG feeding
in acute pancreatitis because ‘pancreatic rest’ is believed to
promote healing, decrease pain, and reduce pancreatic
secretions [29]. It has been shown that significantly higher
secretions of trypsin (P < 0.01) and lipase (P <0.05) occur
in response to the elemental formula delivered into the
duodenum compared to the jejunum (40 cm or more dis-
tal to the ligament of Treitz) in healthy subjects [17].
However, convincing evidence has shown that pancreatic
exocrine function is significantly stronger in healthy sub-
jects compared with patients with acute pancreatitis and
suggests that the severity of acute pancreatitis is inversely
related to duodenal secretion of pancreatic enzymes [30].
Therefore, a more likely alternative explanation for our
findings that the safety and tolerance were not significantly
different between the two nutrient feeding routes is that
the pancreas becomes less responsive to NG stimulation
during an attack of predicted SAP. Increased pancreatic
secretion aggravates pancreatitis and leads to the exacer-
bation of pain. However, we found no significant differ-
ence between NG and NJ feeding with respect to the
exacerbation of pain. Also, only two patients in the NG
groups [12] in all of the included studies required non-opi-
ate analgesia for pain and the others required no analgesia
for re-feeding pain. Therefore, it is logical to speculate that
the degree of re-feeding pain was not high according to
Figure 4 Comparison of exacerbation of pain between nasogastric feeding and nasojejunal feeding groups.
Figure 5 Comparison of diarrhea between nasogastric feeding and nasojejunal feeding groups.
Figure 6 Comparison of achievement of energy balance between nasogastric feeding and nasojejunal feeding groups.
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the GRADE (Grading Assessment, Development and Eva-
luation) framework [31].
Hypermetabolism, with increased resting energy expen-
diture, has been demonstrated in patients with acute pan-
creatitis making nutritional supplements necessary along
with other treatments. No difference in the achievement
of energy balance in our analysis indicated that NG feed-
ing was not inferior to NJ feeding.
Our study has a number of limitations. First, similar to
the study by Petrov et al. [18], the number of subjects in
our meta-analysis was small. Given the absence of robust
power to confirm the results of their meta-analysis, Petrov
et al. systematically reviewed NG feeding in patients with
predicted SAP and demonstrated the necessity to support
the NG approach by adequately powered randomized trials
of NG versus NJ feeding. On the basis of our findings, fol-
lowing the recommendations of the study by Zhang et al.
[32], we calculated that the number of subjects required to
conduct an adequately powered non-inferiority trial was
864. Based on this calculation, our analysis was insufficient
to detect any difference or to prove equivalence between
the NG and NJ groups with respect to clinical outcomes.
However, using a multi-center investigation would provide
an adequate number of subjects. Also, given the large
number of patients in the RCT by Singh et al. [14] com-
pared with the other two RCTs [12,13], we believe that the
addition of the third RCT did substantially increase the
power and the precision of our meta-analysis. Second,
blinding was not performed in any of the trials due to the
nature of the interventions, which increased the bias. How-
ever, the assessed quality of the included RCTs was good.
Third, because two of the included studies [13,14] origi-
nated from the same center in India, we analyzed the dif-
ferences in gender and etiology between the centers in
Scotland and India and unfortunately, found differences.
However, we do not believe that this greatly decreased the
power of the analysis to substantiate the conclusion that
NG feeding is safe and well tolerated compared with NJ
feeding. Although the underlying cause of the pancreatitis
is important in determining the therapy, nutritional sup-
port is necessary in SAP regardless of etiology [33] and the
emphasis has now shifted to early EN [34]. A considerable
delay in commencing EN in each nutrient feeding route
occurred in the RCT from India [14], resulting in a
Figure 7 The number and rates of death, tracheal aspiration, exacerbation of pain, diarrhea, and achievement of energy balance in
the nasogastric and nasojejunal groups. Numbers above the bars indicate the number of incidences in the patients in each group. No
significant difference was found between the two groups.
Table 6 Gender parameters of patients and underlying











Alcohol 12 30 0.02
Idiopathic 3 25
Others 2 7
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potential selection bias. Finally, our funnel plot should be
interpreted with considerable caution given the small
number of studies and patients. Larger studies are required
to confirm our results, because plotting against precision
(1/standard error) emphasizes differences between larger
studies [35] and the capacity of funnel plots to detect bias
is limited when meta-analyses are based on a limited num-
ber of small trials.
Conclusions
In conclusion, although the evidence is not convincing,
our meta-analysis demonstrated that NG feeding is safe
and well tolerated compared with NJ feeding with
respect to the mortality rate, tracheal aspiration, diar-
rhea, exacerbation of pain, and achievement of energy
balance in patients with predicted SAP. EN by NG
appears to provide an alternative to NJ feeding consider-
ing the similar outcomes and convenience. More high-
quality, large-scale, RCTs are needed to validate the use
of NG versus NJ feeding because our review is limited
by the small total sample size and other limitations.
Key messages
• NG feeding is safe and well-tolerated compared with
NJ feeding.
• NG feeding appears to be an alternative to NJ feed-
ing given the similar outcomes and convenience.
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